12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers ThermoGenesis Holdings (NASDAQ:THMO) shares rose 78.7% to $3.77 during Wednesday’s regular session. As of 13:30 EST, this…
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
Wedbush Reiterates Outperform on Elevation Oncology, Maintains $4 Price Target
Wedbush analyst Robert Driscoll reiterates Elevation Oncology (NASDAQ:ELEV) with a Outperform and maintains $4 price target.
‘Medicare Seeks $4.7 Billion From Insurers in Final Audit Rule’ -Bloomberg Law Report
https://news.bloomberglaw.com/health-law-and-business/medicare-seeks-4-7-billion-from-insurers-
SVB Leerink Maintains Market Perform on Elevation Oncology, Lowers Price Target to $1
SVB Leerink analyst Andrew Berens maintains Elevation Oncology (NASDAQ:ELEV) with a Market Perform and lowers the price target from $2 to $1.
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery.
Elevation Oncology Q3 EPS $(1.67) Down From $(0.53) YoY
Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(1.67) per share. This is a 215.09 percent decrease over losses of $(0.53) per share from the same period last year.
HC Wainwright & Co. Assumes Elevation Oncology at Buy, Announces Price Target of $7.5
HC Wainwright & Co. analyst Gobind Singh assumes Elevation Oncology (NASDAQ:ELEV) with a Buy rating and announces Price Target of $7.5.